Vaccination enhances anti-tumor immunity in ovarian cancer following repolarization of the tumor microenvironment with CCR2 blockade

被引:0
|
作者
Cullinan, Darren
Binder, Pratibha
Nywening, Timothy
Wilkinson-Ryan, Ivy
Belt, Brian
Goedegebuure, Peter
Linehan, David
Powell, Matthew
Hawkins, William
机构
关键词
D O I
10.1158/1538-7445.AM2016-2350
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2350
引用
收藏
页数:3
相关论文
共 50 条
  • [21] Nutritional competition within tumor microenvironment dictates anti-tumor immunity
    Fei, Yankang
    Cao, Xuetao
    Liu, Juan
    NATIONAL SCIENCE REVIEW, 2024, 11 (02)
  • [22] The Effects of Radiation Dose Heterogeneity on the Tumor Microenvironment and Anti-Tumor Immunity
    Takashima, Maya E.
    Berg, Tracy J.
    Morris, Zachary S.
    SEMINARS IN RADIATION ONCOLOGY, 2024, 34 (03) : 262 - 271
  • [23] Blockade of CXCR2 mediated granulocytic MDSC recruitment synergizes with CCR2 inhibition of inflammatory monocytes and restores anti-tumor immunity in pancreatic adenocarcinoma
    Nywening, Timothy M.
    Belt, Brian A.
    Panni, Roheena Z.
    Cullinan, Darren
    Sanford, Dominic E.
    Fields, Ryan C.
    Hawkins, William G.
    DeNardo, David G.
    Gillanders, William E.
    Goedegebuure, Peter
    Linehan, David C.
    CANCER RESEARCH, 2016, 76
  • [24] Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
    Aaes, Tania Love
    Kaczmarek, Agnieszka
    Delvaeye, Tinneke
    De Craene, Bram
    De Koker, Stefaan
    Heyndrickx, Liesbeth
    Delrue, Iris
    Taminau, Joachim
    Wiernicki, Bartosz
    De Groote, Philippe
    Garg, Abhishek D.
    Leybaert, Luc
    Grooten, Johan
    Bertrand, Mathieu J. M.
    Agostinis, Patrizia
    Berx, Geert
    Declercq, Wim
    Vandenabeele, Peter
    Krysko, Dmitri V.
    CELL REPORTS, 2016, 15 (02): : 274 - 287
  • [25] Targeting tumor associated myeloid cells with CCR2 inhibitor PF-04136309 enhances gemcitabine/paclitaxel and doxorubicin anti-tumor activity
    Farina, Sasha
    Yang, Hsunhui
    Tu, Guang Huan
    Gamelin, Erick C.
    Lin, John C.
    Wang, Changyu
    Feldman, Reid
    Panowski, Siler
    Oderup, Cecilia
    CANCER RESEARCH, 2017, 77
  • [26] Inhibiting the CCR2/MCP-1 chemokine pathway blocks MDSC recruitment and promotes anti-tumor immunity
    Mittel, Payal
    Wang, Liqing
    Akimova, Tatiana
    Leach, Craig A.
    Clemente, Jose C.
    Sender, Mathew
    Chen, Yao
    Turenen, Brandon
    Hancock, Wayne W.
    CANCER RESEARCH, 2019, 79 (13)
  • [27] Fostriecin potentiates genome instability and anti-tumor immunity in ovarian cancer
    Raja, R.
    Wu, C.
    Butler, K.
    Curtis, M.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S61 - S61
  • [28] FOSTRIECIN POTENTIATES GENOME INSTABILITY AND ANTI-TUMOR IMMUNITY IN OVARIAN CANCER
    Raja, Remya
    Wu, Christopher
    Butler, Kristina
    Curtis, Marion
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A337 - A337
  • [29] Ovarian cancer stem cells: Critical roles in anti-tumor immunity
    Ding, Jing
    Zhang, Yan
    Che, Yan
    FRONTIERS IN GENETICS, 2022, 13
  • [30] PARP-inhibition with IFNg in the ovarian tumor microenvironment induces immunogenic cancer cell death for sustained anti-tumor immunity.
    Kinjyo, Ichiko
    Adams, Sarah F.
    JOURNAL OF IMMUNOLOGY, 2022, 208 (01):